A Study to Evaluate Lu AG06466 in Participants With Fibromyalgia

Stopped early · Phase 1 · Has a placebo group

Conditions studied: Fibromyalgia

In brief

The purpose of this study is to find out the effect of Lu AG06466 on the body in participants with fibromyalgia by assessing pain levels, brain signal changes, and psychiatric (mental) assessments.

Key facts

Study ID
NCT04974359
Run by
H. Lundbeck A/S
People needed
3
Starts
2021-06-24
Expected to finish
2022-01-26
Last updated by the study team
2022-02-11

Who can join

Age: 18 and older, up to 70. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.